Quallich, G.J., et al., “Friedel-Crafts Synthesis of 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone, a Key Intermediate in the Preparation of the Antidepressant Sertraline,”J. Org. Chem. 55:4971-4973 (1990). |
Bogeso, K.P., “Neuroleptic Activity and Dopamine-Uptake Inhibition in 1-Piperazino-3-phenylindans,” J. Med. Chem. 26: 935-947 (1983). |
Bogeso, K.P., et al., “3-Phenyl-1-indanamines. Potential Antidepressant Activity and Potent Inhibition of Dopamine, Norepinephrine, and Serotonin Uptake,” J. Med. Chem. 28:1817-1828 (1985). |
Ganellin, C.R., “Indane and Indene Derivatives of Biological Interest,” Adv. Drug Res. 4:163-249 (1967). |
Barltrop, J.A., et al., “Compounds of Potential Pharmacological Interest. Part IV . Aryl and Alkyl Derivatives of 1-Aminoindane,” J. Chem. Soc. No. 570:2928-2940 (156). |
Feeman, J.F. and Amstutz, E.D., “3-Phenylindones. I. The Synthesis of 6-Chloro-3-(ρ-chlorophenyl)-1-indenone and Some Related Compounds,” J. Am. Chem. Soc. 72:1522-1526 (1950). |
Hyttel, J. and Larsen, J.-J., “Neurochemical Profile of Lu 19-005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and Serotonin,” J. Neurochem. 44:1615-1622 (1985). |
Xavier, L.C., et al., “(S)-Tetrahydro-1-Methyl-3,3-diphenyl-1H,3H-Pyrrolo-[1,2-c][1,3,2]oxazaborole-borane complex,” Organic Syntheses 74: 50-55 (1996). |
Kuck, D., et al., Synthesis of Tribenzotriquinacene by Stereocontrolled Cyclization of Phenyl-Substituted Cs-Diindans (4bα,9,9aα,10-Tetrahydroindeno[1,2-α]indenes), Chemische Berichte. 127 (1):151-165 (1994). |
Simons, J.H. and Archer, S., “Hydrogen fluoride as a condensing agent. VI. The alkylation of benzene with compounds containing an allylic group,” Chemical Abstracts 33(15), Aug. 10, 1939. |